Why GLP-1 Weight-Loss Drugs Don’t Work for Everyone (and What You Can Do About It)
If You’re Not Losing Weight on GLP-1 Drugs, You’re Not Alone
GLP-1 medications like semaglutide and tirzepatide have transformed the way we treat obesity and type 2 diabetes. Stories of dramatic weight loss are everywhere—but many people quietly discover that their own results are far more modest, or sometimes almost nonexistent.
New data reported by The Washington Post highlights one possible reason: two specific genes tied to gut hormones may help determine how your body responds to GLP-1 drugs. In other words, for some people, biology—not “willpower”—may be the main barrier.
This article walks you through what researchers are finding, what it means for your expectations, and practical steps you can take if you’re not seeing the scale move the way you hoped.
The Problem: Powerful Drugs, Uneven Results
In large clinical trials, people on GLP-1 drugs often lose around 15% (and sometimes more) of their starting body weight over about a year. But those are averages. When you zoom in, you see three broad groups:
- High responders: People who lose far more than the average.
- Typical responders: People whose results match trial averages.
- Low or non-responders: People who lose little weight, or none at all.
This variation has frustrated patients and clinicians alike. Until recently, we had only partial answers: differences in diet, physical activity, sleep, other medications, and adherence to injections all matter. But they didn’t fully explain why some people barely budge on the scale, even when they “do everything right.”
“Any time we see such a wide range of responses to the same dose, it’s a clue that underlying biology—especially genetics—is playing a big role.”
— Endocrinologist quoted in recent coverage of GLP-1 research
What the New Research Suggests: Two Gut-Hormone Genes
The new study referenced by The Washington Post focuses on two genes involved in gut hormones that help regulate appetite and digestion. While details are still emerging, the big picture is this:
- GLP-1 drugs mimic natural gut hormones. They slow stomach emptying, reduce hunger, and improve blood sugar control.
- Some people have genetic variants that change how their gut and brain respond to these hormone signals.
- Those variants may blunt the weight-loss effect of GLP-1 medications, even at standard doses.
In plain language: if your genes cause your hormone receptors or signaling pathways to behave differently, the same injection may feel like a gentle nudge instead of a strong appetite-suppressing signal.
What This Means for Your Weight-Loss Expectations
Knowing that genes may shape how you respond can change the conversation in important ways:
- It’s not a personal failure if you’re not losing as quickly as others.
- Your “best possible” result may look different from social media success stories.
- Other health benefits still matter: improved blood sugar, blood pressure, or fatty liver—even with less visible weight loss—are clinically important.
In obesity medicine, the goal is rarely a perfect number on the scale. A sustained weight loss of 5–10% can significantly reduce the risk of diabetes complications, sleep apnea, and heart disease—even if it doesn’t match the dramatic transformations often highlighted online.
Why GLP-1 Drugs May Not Work Well for You
Genetics are just one piece of a bigger puzzle. If you aren’t losing weight on a GLP-1 drug, clinicians usually walk through several possible contributors:
1. Biological Factors
- Genetic variants in gut-hormone pathways that dull the drug’s appetite effects.
- Underlying medical conditions like Cushing’s syndrome, hypothyroidism, PCOS, or certain brain disorders.
- Medications that promote weight gain (some antidepressants, antipsychotics, steroids, certain diabetes drugs).
- Very high baseline insulin or severe insulin resistance, which can make fat loss slower.
2. Treatment-Related Factors
- Sub-therapeutic dose: you may still be on a lower step of the titration schedule.
- Missed or delayed doses because of side effects, travel, or supply issues.
- Improper injection technique or storing the medication outside its recommended temperature range.
3. Lifestyle & Environmental Factors
- Liquid calories (alcohol, sugary drinks, fancy coffee) that bypass appetite cues.
- “Compensation” eating on weekends or during stress that cancels weekday deficits.
- Very low sleep, chronic stress, or shift work—each alters hunger hormones and cravings.
- Minimal activity causing muscle loss and slower metabolic rate over time.
“Medication is a tool, not a cure. If we layer it on top of unaddressed medical, psychological, and lifestyle factors, we shouldn’t expect it to fix everything on its own.”
— Obesity medicine specialist, clinical commentary
A Real-World Example: Two Patients, Same Drug, Different Outcomes
Consider two fictional patients whose stories echo many clinic experiences:
- Patient A: Starts semaglutide at a BMI of 38. Over 12 months, they lose about 20% of their body weight. Their appetite drops dramatically, and they naturally shift toward smaller portions and fewer snacks.
- Patient B: Starts at a similar BMI on the same dose schedule. Their appetite decreases a bit, but cravings remain strong, and weight loss stalls at around 5%, despite consistent dosing.
When Patient B’s care team reviews the case, they find three compounding issues: a medication that promotes weight gain, untreated sleep apnea, and a suspected genetic pattern that blunts response to GLP-1 drugs. Adjusting medications, treating sleep apnea, and adding behavioral strategies eventually improves weight loss and, more importantly, metabolic health—even though the total weight loss never matches Patient A’s.
Practical Steps If You’re Not Losing Weight on a GLP-1 Drug
If your weight loss has stalled or never really started, you can use this step-by-step checklist with your healthcare provider:
- Clarify what “success” means for you.
Is the priority diabetes control, joint pain relief, sleep apnea, fertility, or weight itself? Aligning treatment with your top goals can change which outcomes matter most. - Review your dose and schedule.
Ask: Are you at a maintenance dose? Did you pause or reduce the dose because of side effects or supply shortages? Sometimes, carefully titrating upward (if safe) restores effectiveness. - Audit other medications and health conditions.
Bring an updated list of all medications and supplements. Ask whether any could be promoting weight gain or interacting with your GLP-1. - Look at “stealth calories.”
Many people find that the drug helps with portion control at meals but not with:- Alcohol or sugary drinks
- Evening snacking in front of screens
- “Reward” foods after stressful days
- Check sleep and stress.
Poor sleep and chronic stress both push appetite hormones in the wrong direction and can overpower medication effects. - Ask about other biological contributors.
Depending on your history, your clinician may screen for thyroid disorders, Cushing’s, PCOS, or sleep apnea. - Discuss whether you might be a low responder.
If everything else checks out, your provider may consider that genetics could be limiting your response and talk through options like switching molecules, combining treatments, or adjusting long-term expectations.
Beyond the Scale: Other Meaningful Wins on GLP-1 Therapy
Even when the scale moves slowly, GLP-1 medications can drive important changes inside the body:
- Lower average blood glucose (A1c) and fewer highs and lows
- Reduced risk of certain cardiovascular events in high-risk patients (based on trial data for some GLP-1 drugs)
- Improved fatty liver markers in some individuals
- Less “food noise” or obsessive thinking about eating
- Better portion control and a more predictable appetite rhythm
These benefits don’t erase the emotional impact of slower weight loss, but they are real, measurable health gains that deserve recognition when you’re evaluating whether treatment is “working.”
The Future: Toward More Personalized Obesity Treatment
The discovery of gut-hormone genes linked to GLP-1 response is part of a broader shift toward personalized obesity care. Researchers are exploring:
- Genetic profiles that predict which medication class is likely to be most effective
- Combination therapies that target multiple appetite and metabolic pathways at once
- Microbiome (gut bacteria) patterns that may interact with GLP-1 signaling
- Digital tools and wearables that integrate medication data with sleep, activity, and glucose trends
We’re not yet at the point where a simple test can tell you exactly which drug and dose will work best. But each new study moves us closer to treatments that are chosen for you, not just for your diagnosis.
Common Emotional Obstacles—and How to Navigate Them
Slower or minimal weight loss on a highly publicized drug can stir up a lot of difficult feelings: shame, frustration, even grief. Those emotions are valid—and they can quietly undermine your progress if they’re not addressed.
- Comparing yourself to others: Try shifting focus from “How do I compare?” to “What’s changing in my own health?” This includes lab values, energy, and daily function.
- All-or-nothing thinking: If you didn’t lose as much as you hoped, it can feel like the whole effort was pointless. Remind yourself that partial benefits are still benefits.
- Stigma and self-blame: Understanding that genetics and biology matter can help reframe weight as a chronic, treatable condition—not a moral issue.
Taking Your Next Step—On Your Terms
If you’ve been wondering, “Why am I not losing weight on this GLP-1 drug?”, you’re asking a smart and important question. Emerging research on gut-hormone genes offers one possible answer: your body’s wiring may simply respond differently. That doesn’t mean you’ve failed—and it doesn’t mean you’re out of options.
Your most powerful move now is to bring these questions to your healthcare team:
- Review your current response and side effects.
- Explore possible biological and lifestyle contributors.
- Discuss whether continuing, adjusting, or changing therapies makes sense for you.
Your weight and your health are not defined by how closely your story matches a headline or a social media post. They’re defined by the small, sustainable changes you make over time—and by treatments that fit your unique biology, your life, and your values.
If you’re ready, schedule a focused visit with your clinician specifically to talk about your GLP-1 response. Bring your questions, your data, and your concerns. You deserve care that sees the whole picture—not just the number on the scale.
Further Reading & Resources
For more in-depth, evidence-based information on GLP-1 medications and obesity treatment, you may find these resources helpful:
- U.S. National Institutes of Health – Weight Management Overview
- American Diabetes Association – Medications to Treat Diabetes
- Obesity Medicine Association – Patient Care Resources
